Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Treatment of Leukemia
Clinical trial NCT06898983 · RECRUITING
Trial details
- NCT number
- NCT06898983
- Sponsor
- Anhui Provincial Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-14
- Primary completion
- 2026-06-30
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.